Mirxes Holding Company Limited (HKG:2629)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.41
-3.15 (-20.24%)
Mar 31, 2026, 4:08 PM HKT

Mirxes Holding Company Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2024FY 2023FY 2022
Period EndingJun '25 Dec '24 Dec '23 Dec '22
Revenue
21.1920.2824.1917.76
Revenue Growth
19.30%-16.13%36.19%-
Gross Profit
11.328.8913.599.33
Operating Income
-66.88-73.75-58.66-47.76
Net Income
-76.23-92.33-69.23-56.64
Earnings Per Share
-0.56-0.77-0.58-0.47
EPS Growth
----

Revenue by Segment

Fiscal YearTTMFY 2024FY 2023FY 2022
Period EndingJun '25 Dec '24 Dec '23 Dec '22
Early Detection and Precision Multi-Omics
21.1617.6517.4810.27
Infectious Diseases
-2.636.77.49
Total
21.1920.2824.1917.76

Cash & Debt

Fiscal YearCurrentFY 2024FY 2023FY 2022
Period EndingJun '25 Dec '24 Dec '23 Dec '22
Cash & Investments
108.366.021621.16
Total Debt
23.15242.58209.81150.44
Net Cash (Debt)
85.21-236.56-193.81-129.28
Net Cash Growth
----
Net Cash Per Share
0.62-1.97-1.61-1.08

Cash Flow & CapEx

Fiscal YearTTMFY 2024FY 2023FY 2022
Period EndingJun '25 Dec '24 Dec '23 Dec '22
Operating Cash Flow
-31.01-29.76-42.54-48.68
Capital Expenditures
-1.23-1.74-3.47-20.62
Free Cash Flow
-32.24-31.51-46.01-69.31
Free Cash Flow Growth
----

Margins

Fiscal YearTTMFY 2024FY 2023FY 2022
Period EndingJun '25 Dec '24 Dec '23 Dec '22
Gross Margin
53.45%43.82%56.18%52.56%
Operating Margin
-315.65%-363.62%-242.54%-268.92%
Pretax Margin
-375.27%-471.54%-287.29%-314.09%
Profit Margin
-359.78%-455.20%-286.23%-318.95%
FCF Margin
-152.17%-155.33%-190.24%-390.27%